Alzheimer’s Disease (AD) is a progressive neurodegenerative disorder that
primarily affects cognitive and functional abilities. While much study has focused on
the basic pathology of AD, the role of comorbidities in influencing its progression has
gained increasing attention. Comorbidities, such as cardiovascular diseases, diabetes,
depression, and sleep disorders, are highly prevalent in individuals with AD and
significantly impact its trajectory, outcomes, and management. This chapter focuses on
the intricate interplay between Alzheimer’s disease and common comorbid conditions,
highlighting how these comorbidities contribute to faster cognitive decline, worsened
behavioral symptoms, and increased caregiver burden. Key mechanisms linking
comorbidities to AD progression, including chronic inflammation, vascular
dysfunction, metabolic dysregulation, and oxidative stress, are discussed in detail.
These processes increase neuronal damage and can accelerate the formation of
amyloid-beta and tau proteins, indicators of AD pathology. The chapter also addresses
the clinical challenges posed by comorbidities in AD patients, such as diagnostic
complexities, polypharmacy, and the lack of tailored management guidelines. Practical
strategies for effective management are outlined, including comprehensive
assessments, personalized care plans, and the merging of pharmacological and nonpharmacological treatments. The role of multidisciplinary teams in optimizing patient
outcomes is emphasized, along with emerging research into novel therapeutic targets
and biomarkers for early detection and intervention. This chapter aims to provide a
significant resource for healthcare practitioners, researchers, and caregivers, promoting
a more complete approach to managing Alzheimer’s disease in the presence of
comorbidities.
Keywords: Alzheimer’s disease, Biomarkers, Cognitive decline, Comorbidities, Integrated care, Metabolic disorders, Vascular dysfunction.
